‌

US Patent 8304441 Thiazolidinedione analogues for the treatment of metabolic diseases

Patent 8304441 was granted and assigned to Metabolic Solutions Development Company on November, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

‌

Metabolic Solutions Development Company

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

83044410

Patent Inventor Names

Tim Parker0

Gerard R. Colca0

Robert C. Gadwood0

Date of Patent

November 6, 2012

Patent Application Number

132796570

Date Filed

November 16, 2011

Patent Primary Examiner

‌

Golam M. M. Shameem

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8304441 Thiazolidinedione analogues for the treatment of metabolic diseases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API